Tier 3 · Filer Universe
Atrium Therapeutics, Inc.
RNA · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.
Price
$12.33
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0002093101
Liquidity rank
#3789
Observed dollar volume
Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.
SEC XBRL facts
| Field | Value | Period end | Filing |
|---|---|---|---|
| Annual revenue | Not published | Not published | No matching frame |
| Annual diluted EPS | Not published | Not published | No matching frame |
| Quarterly revenue | $19.64M | 2026-03-31 | 0001193125-26-224243 |
| Quarterly diluted EPS | -0.97 | 2026-03-31 | 0001193125-26-224243 |
SEC EDGAR Frames batch generated 2026-08-10T23:34:18.973Z. Frames are calendar-aligned and may not cover every filer or fiscal period.
Filings and machine access
Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract
Context paths
HealthcareNasdaqDHR · Tier 1 peerABT · Tier 1 peerBMY · Tier 1 peerTMO · Tier 1 peer
Provenance
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames